Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy.

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.

HHS Secretary Robert F. Kennedy Jr. outlines reasons for U.S. withdrawal from WHO, highlighting failures in COVID-19 response and China's influence on the organization.

India has remained largely unaffected by the recent surge in Covid cases, with the government maintaining that the situation is under control.

As COVID-19 cases rise in Southeast Asia, India is also experiencing a slight increase in infections, with current active cases at 257. Health officials report that most infections are mild and hospitalisations are not needed.

Covid-19 cases have surged in several Asian countries, including Hong Kong, Singapore, and Thailand. India, however, reports a mild increase.

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration. Top officials for the Food and Drug Administration laid out new requirements for yearly updates to COVID shots,